Targeting EGFR L858R/T790M/C797S allosteric sites for NSCLC therapy: Molecules with novel multi-kinase binding potential - Current Issue

Targeting EGFR L858R/T790M/C797S allosteric sites for NSCLC therapy: Molecules with novel multi-kinase binding potential - Current Issue - IJSR